Endothelium‐derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels
Open Access
- 1 November 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 95 (3), 835-843
- https://doi.org/10.1111/j.1476-5381.1988.tb11712.x
Abstract
1 The role of endothelium-derived relaxing factor (EDRF) in the action of vasodilator (acetylcholine, histamine, nitroprusside) and vasoconstrictor (noradrenaline, vasopressin) drugs on vascular resistance in the isolated perfused kidney and mesentery of the rat was studied. 2 Acetylcholine (EC50 = 0.18 ± 0.05 nmol and 3.1 ± 0.06 nmol, n = 8) and histamine (EC50 = 31.2 ± 4.9 nmol and 46.2 ± 3.9 nmol, n = 8) produced dose-related vasodilatation in noradrenaline-preconstricted (i.e. ‘high tone’) rat renal and mesenteric blood vessels. The response to both vasodilators (but not nitroprusside) was abolished by infusion of CHAPS (4.7 mg ml−1, 30 s). By use of an immunocytochemical staining procedure CHAPS was demonstrated to remove vascular endothelial cells lining intrarenal blood vessels. 3 Gossypol (3 μm), metyrapone (10 μm) and nordihydroguaiaretic acid, (NDGA, 30 μm), presumed inhibitors of EDRF biosynthesis, reduced or abolished the response to acetylcholine and histamine in perfused kidney and mesentery of the rat without affecting vasodilatation due to nitroprusside. Mepacrine (10 μm) similarly abolished the response to acetylcholine and histamine but in addition, reduced the response to nitroprusside in both preparations. 4 Methylene blue (100 μm), a presumed antagonist of the effect of EDRF, abolished vasodilatation due to acetylcholine and histamine and reduced the response to nitroprusside in perfused rat kidney and mesentery. Superoxide dismutase, SOD (15 u ml−1), was without effect. 5 While CHAPS treatment significantly augmented the vasoconstrictor response to both noradrenaline and vasopressin in perfused renal and mesenteric vessels this effect was not mimicked by metyrapone or gossypol suggesting that the enhanced effect of vasopressor agents in CHAPS-perfused rat organs is due to the removal of a permeability barrier rather than impaired EDRF formation. 6 Responses to vasoconstrictor and vasodilator drugs in the perfused kidney and mesentery were obtained in the presence of indomethacin (8/XM) which produced in excess of 90% inhibition of prostacyclin (PGI2) release as measured by radioimmunoassay of 6-oxo-prostaglandin F1α (6-oxo-PGF1α) in the Krebs effluent. 7 We provide evidence that EDRF mediates the vasodilator response to acetylcholine and histamine in resistance blood vessels in perfused rat kidney and mesentery. The possibility that EDRF has a physiological role to play in regulating the calibre of resistance blood vessels is discussed.This publication has 28 references indexed in Scilit:
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Characterization of vascular relaxant factor released from cultured endothelial cells.Hypertension, 1987
- Evidence for Endothelium-Dependent Vasodilation of Resistance Vessels by AcetylcholineJournal of Vascular Research, 1987
- Modulation of Vascular Smooth Muscle Contraction by the EndotheliumAnnual Review of Physiology, 1986
- MRC OX-45 antigen: A leucocyte/endothelium rat membrane glycoprotein of 45,000 molecular weightMolecular Immunology, 1986
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brainNature, 1985
- Potentiation of KCl-induced Vasoconstriction by Saponin Treatment in Isolated Canine Mesenteric ArteriesThe Japanese Journal of Pharmacology, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolismNature, 1976